CurrentCardio
Get Weekly

CurrentCardio coverage · page 7 of 13

EP Europace

Briefs 241–280 of 488 CurrentCardio has covered from this journal, newest publication first

Latest from EP Europace

All coverage, newest first

  1. Europace

    Effect of targeted education of patients with atrial fibrillation on unplanned cardiovascular outcomes: results of the multicentre randomized AF-EduCare trial

    Randomised controlled trialArrhythmias & EP

  2. Europace

    Improving atrial fibrillation or flutter detection and management by smartphone-based photoplethysmography rhythm monitoring following cardiac surgery: a pragmatic randomized trial

    Randomised controlled trialArrhythmias & EP

  3. Europace

    Aetiology and haemodynamic patterns of orthostatic hypotension in a tertiary syncope unit

    Cohort studyArrhythmias & EP

  4. Europace

    Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study

    Cohort studyArrhythmias & EP

  5. Europace

    Socio-economic position and sudden cardiac death: a Danish nationwide study

    Cohort studyArrhythmias & EP

  6. Europace

    Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial

    Secondary analysisArrhythmias & EP

  7. Europace

    Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis

    Cohort studyCardio-oncology & other

  8. Europace

    Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

    Guideline or statementArrhythmias & EP

  9. Europace

    Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review

    Meta-analysisArrhythmias & EP

  10. Europace

    Ventricular septal defect characteristics influence presence of septal anatomical isthmuses in patients with repaired tetralogy of Fallot

    Cohort studyCongenital

  11. Europace

    Using computed tomography atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: the UTMOST AF II randomized clinical trial

    Randomised controlled trialArrhythmias & EP

  12. Europace

    Multielectrode catheter-based pulsed electric field vs. cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis

    Meta-analysisArrhythmias & EP

  13. Europace

    General anaesthesia and deep sedation for monopolar pulsed field ablation using a lattice-tip catheter combined with a novel three-dimensional mapping system

    Cohort studyArrhythmias & EP

  14. Europace

    Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study

    Cohort studyArrhythmias & EP

  15. Europace

    aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study

    Cohort studyArrhythmias & EP

  16. Europace

    Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?

    Cohort studyArrhythmias & EP

  17. Europace

    Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study

    Cohort studyArrhythmias & EP

  18. Europace

    Temperature-guided high and very high-power short duration ablation for atrial fibrillation treatment: the peQasus multicentre study

    Cohort studyArrhythmias & EP

  19. Europace

    Anatomical vs. electrophysiological approach for ablation of premature ventricular contractions originating from the left ventricular summit (ISESHIMA-SUMMIT Study)

    Cohort studyArrhythmias & EP

  20. Europace

    Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry

    Cohort studyArrhythmias & EP

  21. Europace

    Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED study

    Cohort studyArrhythmias & EP

  22. Europace

    Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC

    Guideline or statementHeart failure

  23. Europace

    Mapping and ablation of ventricular tachycardia using dual-energy lattice-tip focal catheter: early feasibility and safety study

    Cohort studyArrhythmias & EP

  24. Europace

    Ultrasound-guided vs. fluoro-guided axillary venous access for cardiac implantable electronic devices: a patient-based meta-analysis

    Meta-analysisArrhythmias & EP

  25. Europace

    Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling

    Cohort studyHeart failure

  26. Europace

    Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study

    Randomised controlled trialHeart failure

  27. Europace

    Carotid sinus massage in clinical practice: the Six-Step-Method

    Guideline or statementArrhythmias & EP

  28. Europace

    Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study

    Cohort studyArrhythmias & EP

  29. Europace

    Early rapid local impedance drop is associated with acute lesion efficacy during pulmonary vein isolation

    Cohort studyArrhythmias & EP

  30. Europace

    Transcatheter non-acute retrieval of the tine-based leadless ventricular pacemaker

    Cohort studyArrhythmias & EP

  31. Europace

    Multipoint pacing is associated with improved prognosis and cardiac resynchronization therapy response: MORE-CRT MPP randomized study secondary analyses

    Secondary analysisHeart failure

  32. Europace

    Improved outcomes with leadless vs. single-chamber transvenous pacemaker in haemodialysis patients

    Cohort studyArrhythmias & EP

  33. Europace

    Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall

    Cohort studyArrhythmias & EP

  34. Europace

    Multielectrode catheter-based pulsed field ablation of persistent and long-standing persistent atrial fibrillation

    Cohort studyArrhythmias & EP

  35. Europace

    Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention

    Cohort studyArrhythmias & EP

  36. Europace

    Smartphone app-based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: data from the TeleCheck-AF project

    Secondary analysisArrhythmias & EP

  37. Europace

    Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network

    Cohort studyArrhythmias & EP

  38. Europace

    Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study

    Cohort studyHeart failure

  39. Europace

    Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study

    Randomised controlled trialArrhythmias & EP

  40. Europace

    Novel systematic processing of cardiac magnetic resonance imaging identifies target regions associated with infarct-related ventricular tachycardia

    Mechanistic studyArrhythmias & EP

All 488 Briefs in ExploreShowing Briefs 241–280 of 488, newest first